Keppra (Levetiracetam) & Anaphylaxis and Angioedema

    Basic Details
    Status
    Complete
    Last Updated
    Thursday, November 30, 2017
    Health Outcome(s)
    anaphylaxis
    angioedema
    Purpose
    Mini-Sentinel
    Meets requirements of FD&C Act Sec 505(o) prior to requiring a PMR
    No
    Regulatory Determination / Use

    Drug Safety Label Change, Warnings and Precautions